Designed Biologics Inc.

Designed Biologics is pioneering the next generation of precision diagnostics and therapeutics with a specialized focus on high-affinity, nano IgG-like antibodies and custom-engineered peptides. Leveraging cutting-edge AI and high-performance computing, we rapidly generate small peptides (30-75 amino acids) and potent inhibitors that target and deactivate even the most challenging proteins, including those previously considered undruggable. Our platform guarantees unparalleled specificity, screening candidates against the entire human proteome to eliminate undesired interactions. With a 100% experimental success rate and a typical 50% candidate binding rate, our technology delivers robust solutions across therapeutics, diagnostics, and research. From ELISA technology for protein quantification to designing multi-target inhibitors, we’re setting new standards in biotechnology. Designed Biologics thrives in bridging advanced science and real-world applications to redefine what's possible in medical science.